Pivalate

Pivalate

SCHEMBL28032650

CC(C)(C)C(=O)O.Cc1ccn(C)n1

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.39
NPC1 O15118 5/20 0.39
JMJD6 Q6NYC1 1/20 0.39
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 4/20 0.38
ALDH1A1 P00352 3/20 0.38
KDM4E B2RXH2 3/20 0.38
HTT P42858 2/20 0.38
LMNA P02545 2/20 0.38
TSHR P16473 1/20 0.36
MAPT P10636 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
ATM Q13315 1/20 0.36
NOS1 P29475 1/20 0.36
USP2 O75604 1/20 0.36
ALOX15 P16050 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
GAA P10253 1/20 0.35
PLAU P00749 1/20 0.34
ELANE P08246 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL75314 0.81
Succinic Acid SCHEMBL22123041 0.81 KDM4E (0.45) RAB9ANPC1JMJD6KMT2ASMN1; SMN2
Hydrochloric Acid SCHEMBL27901405 0.79
Phosphoric Acid SCHEMBL7647885 0.78 RAB9A (0.42) RAB9ANPC1JMJD6KMT2ASMN1; SMN2
SCHEMBL2551980 0.77 KMT2A (0.40) RAB9ANPC1JMJD6KMT2ASMN1; SMN2
SCHEMBL12436779 0.74 LMNA (0.40) RAB9ANPC1SMN1; SMN2ALDH1A1KDM4E
SCHEMBL17477604 0.74 KEAP1 (0.39) RAB9ANPC1JMJD6KMT2ASMN1; SMN2
Pyridine SCHEMBL28098609 0.72 KMT2A (0.45) RAB9ANPC1JMJD6KMT2ASMN1; SMN2
SCHEMBL29296509 0.71 NOS1 (0.50) RAB9AKMT2ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL8244373 0.71 SMN1; SMN2 (0.45) RAB9ANPC1KMT2ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104968345-A 1, 5-naphthyridine derivatives and MELK inhibitors containing 1, 5-naphthyridine derivatives ONCOTHERAPY SCIENCE INC 2015-10-07 CN disclosed